Biomaker evaluation for major adverse cardiovascular event development in patients undergoing cardiac Surgery [0.03%]
心脏手术患者生物标志物与主要心血管事件发病风险评估之间的关系研究
Claudia E Imperiali,Juan C Lopez-Delgado,Macarena Dastis-Arias et al.
Claudia E Imperiali et al.
Objectives: The postoperative period of cardiac surgery (CS) is associated with the development of major adverse cardiovascular events (MACEs). However, the evaluation of MACE after CS by means of biomarkers is poorly dev...
Lactose tolerance test as an alternative to hydrogen breath test in the study of lactose malabsorption [0.03%]
乳糖耐量试验作为氢气呼气试验在乳糖吸收不良研究中的替代方法
Teresa Sendino,Amaia Sandúa,Sofía Calleja et al.
Teresa Sendino et al.
Objectives: Lactose malabsorption is generally assessed by hydrogen breath testing (HBT). However, this test is not recommended in patients with high baseline hydrogen concentrations (H2B). In addition, breath testing is ...
VALIDA project: Validation of allergy in vitro diagnostics assays (Tools and recommendations for the assessment of in vitro tests in the diagnosis of allergy) [0.03%]
VALIDA项目：过敏体外诊断试验的验证（评估体外试验在过敏诊断中的工具和建议）
María L Casas,Ángel Esteban,Miguel González-Muñoz et al.
María L Casas et al.
In vitro allergen-specific immunoglobulin E (IgE) detection and quantification tests are routinely performed in clinical laboratories to diagnose patients with a suspected allergy. Numerous commercial assays are available to test for allerg...
Challenges of COVID-19 [0.03%]
新冠疫情的挑战
Ignacio López-Goñi
Ignacio López-Goñi
Giuseppe Lippi
Giuseppe Lippi
Alberto Vílchez Rodríguez,Julia González Cantó,Sara Esteve Poblador et al.
Alberto Vílchez Rodríguez et al.
Objectives: Clinical laboratories should use only validated procedures. Precision is an important factor in the validation and verification of a new measurement procedure. Our objective was to verify the precision and tru...
Cristina A López Rodríguez,Marc Boigues Pons,Bibiana Quirant Sánchez et al.
Cristina A López Rodríguez et al.
CYFRA 21-1 in patients with suspected cancer: evaluation of an optimal cutoff to assess the diagnostic efficacy and prognostic value [0.03%]
评估 CYFRA 21-1 诊断截断值以提高肺癌诊断效能及预后价值研究
Sonsoles Garcia-Valdecasas Gayo,Maria Jesus Ruiz-Alvarez,Daniel Gonzalez-Gay et al.
Sonsoles Garcia-Valdecasas Gayo et al.
Objectives: Chosen cutoff for cytokeratin 19 fragment antigen (CYFRA 21-1) as a tumor biomarker considerably influences its diagnostic and prognostic usefulness. The aim of the present study is to determine an optimal cut...
A variant of the gene HARS detected in the clinical exome: etiology of a peripheral neuropathy undiagnosed for 20 years [0.03%]
临床外显子组中检测到的HARS基因变异：一种历时20年未诊断的周围神经病的原因
Raquel Lahoz Alonso,Paula Sienes Bailo,Jose Luis Capablo Liesa et al.
Raquel Lahoz Alonso et al.
Objectives: Describe a case with axonal Charcot-Marie-Tooth (CMT) type 2W, a neurological disease characterized by peripheral neuropathy typically involving the lower limbs and causing gait alterations and distal sensory-...